Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization

Laurelle Jackson, Hylton Rodel, Shi-Hsia Hwa, Sandile Cele, Yashica Ganga, Houriiyah Tegally, Mallory Bernstein, Jennifer Giandhari, COMMIT-KZN Team, Bernadett I. Gosnell, Khadija Khan, Willem Hanekom, Farina Karim, View ORCID ProfileTulio de Oliveira, Mahomed-Yunus S. Moosa, View ORCID ProfileAlex Sigal
doi: https://doi.org/10.1101/2021.06.01.446516
Laurelle Jackson
1Africa Health Research Institute, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hylton Rodel
1Africa Health Research Institute, Durban, South Africa
2Division of Infection and Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shi-Hsia Hwa
1Africa Health Research Institute, Durban, South Africa
2Division of Infection and Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandile Cele
1Africa Health Research Institute, Durban, South Africa
3School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yashica Ganga
1Africa Health Research Institute, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Houriiyah Tegally
4KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mallory Bernstein
1Africa Health Research Institute, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Giandhari
4KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadett I. Gosnell
5Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khadija Khan
1Africa Health Research Institute, Durban, South Africa
3School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem Hanekom
1Africa Health Research Institute, Durban, South Africa
2Division of Infection and Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farina Karim
1Africa Health Research Institute, Durban, South Africa
3School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tulio de Oliveira
4KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
6Centre for the AIDS Programme of Research in South Africa, Durban 4001, South Africa
7Department of Global Health, University of Washington, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tulio de Oliveira
Mahomed-Yunus S. Moosa
5Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Sigal
1Africa Health Research Institute, Durban, South Africa
2Division of Infection and Immunity, University College London, London, UK
8Max Planck Institute for Infection Biology, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex Sigal
  • For correspondence: alex.sigal@ahri.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Viruses increase the efficiency of close-range transmission between cells by manipulating cellular physiology and behavior, and SARS-CoV-2 uses cell fusion as one mechanism for cell-to-cell spread. Here we visualized infection using time-lapse microscopy of a human lung cell line and used live virus neutralization to determine the sensitivity of SARS-CoV-2 cell-to-cell spread to neutralizing antibodies. SARS-CoV-2 infection rapidly led to cell fusion, forming multinucleated cells with clustered nuclei which started to be detected at 6h post-infection. To compare sensitivity of cell-to-cell spread to neutralization, we infected either with cell-free virus or with single infected cells expressing on their surface the SARS-CoV-2 spike protein. We tested two variants of SARS-CoV-2: B.1.117 containing only the D614G substitution, and the escape variant B.1.351. We used the much smaller area of single infected cells relative to infection foci to exclude any input infected cells which did not lead to transmission. The monoclonal antibody and convalescent plasma we tested neutralized cell-free SARS-CoV-2, with the exception of B.1.351 virus, which was poorly neutralized with plasma from non-B.1.351 infections. In contrast, cell-to-cell spread of SARS-CoV-2 showed no sensitivity to monoclonal antibody or convalescent plasma neutralization. These observations suggest that, once cells are infected, SARS-CoV-2 may be more difficult to neutralize in cell types and anatomical compartments permissive for cell-to-cell spread.

Competing Interest Statement

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted June 01, 2021.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization
Laurelle Jackson, Hylton Rodel, Shi-Hsia Hwa, Sandile Cele, Yashica Ganga, Houriiyah Tegally, Mallory Bernstein, Jennifer Giandhari, COMMIT-KZN Team, Bernadett I. Gosnell, Khadija Khan, Willem Hanekom, Farina Karim, Tulio de Oliveira, Mahomed-Yunus S. Moosa, Alex Sigal
bioRxiv 2021.06.01.446516; doi: https://doi.org/10.1101/2021.06.01.446516
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization
Laurelle Jackson, Hylton Rodel, Shi-Hsia Hwa, Sandile Cele, Yashica Ganga, Houriiyah Tegally, Mallory Bernstein, Jennifer Giandhari, COMMIT-KZN Team, Bernadett I. Gosnell, Khadija Khan, Willem Hanekom, Farina Karim, Tulio de Oliveira, Mahomed-Yunus S. Moosa, Alex Sigal
bioRxiv 2021.06.01.446516; doi: https://doi.org/10.1101/2021.06.01.446516

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4378)
  • Biochemistry (9571)
  • Bioengineering (7082)
  • Bioinformatics (24821)
  • Biophysics (12595)
  • Cancer Biology (9944)
  • Cell Biology (14333)
  • Clinical Trials (138)
  • Developmental Biology (7942)
  • Ecology (12092)
  • Epidemiology (2067)
  • Evolutionary Biology (15979)
  • Genetics (10914)
  • Genomics (14726)
  • Immunology (9859)
  • Microbiology (23633)
  • Molecular Biology (9472)
  • Neuroscience (50815)
  • Paleontology (369)
  • Pathology (1538)
  • Pharmacology and Toxicology (2677)
  • Physiology (4005)
  • Plant Biology (8651)
  • Scientific Communication and Education (1508)
  • Synthetic Biology (2389)
  • Systems Biology (6420)
  • Zoology (1345)